Increased Circulating Chemerin in Relation to Chronic Microvascular Complications in Patients with Type 2 Diabetes

Objective. Type 2 diabetes (T2DM) is a global epidemic and increases mortality due to its vascular complications. Chemerin has been found to exert a major role in glucose and lipid metabolism. The aim of this study was to explore the correlation between plasma chemerin levels and microangiopathy in...

Full description

Saved in:
Bibliographic Details
Main Authors: Ping Gu, Wei Wang, Yue Yao, Yixin Xu, Liping Wang, Pu Zang, Jian Ma, Cuihua Yang, Junya Liang, Bin Lu, Jiaqing Shao
Format: Article
Language:English
Published: Wiley 2019-01-01
Series:International Journal of Endocrinology
Online Access:http://dx.doi.org/10.1155/2019/8693516
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832554606980235264
author Ping Gu
Wei Wang
Yue Yao
Yixin Xu
Liping Wang
Pu Zang
Jian Ma
Cuihua Yang
Junya Liang
Bin Lu
Jiaqing Shao
author_facet Ping Gu
Wei Wang
Yue Yao
Yixin Xu
Liping Wang
Pu Zang
Jian Ma
Cuihua Yang
Junya Liang
Bin Lu
Jiaqing Shao
author_sort Ping Gu
collection DOAJ
description Objective. Type 2 diabetes (T2DM) is a global epidemic and increases mortality due to its vascular complications. Chemerin has been found to exert a major role in glucose and lipid metabolism. The aim of this study was to explore the correlation between plasma chemerin levels and microangiopathy in patients with T2DM. Methods. A total of 598 T2DM patients were classified into two groups: with and without microvascular complications. Anthropometric parameters and blood pressure were taken. The amounts of glycosylated hemoglobin, glucose, lipid profiles, creatinine, and chemerin concentrations in the blood were determined. The presence and severity of nephropathy, retinopathy, and neuropathy were also evaluated by specific tests. Results. Plasma levels of chemerin in diabetic subjects with microvascular complications were markedly elevated compared to those without. The number of microvascular complications increased with high plasma chemerin levels. Patients with high chemerin levels had an increased incidence of nephropathy and retinopathy. Furthermore, the chemerin plasma concentrations increased with the progression of diabetic nephropathy with highest values in macroalbuminuria groups. In contrast, no significant difference was observed in plasma chemerin levels between subjects with and without peripheral neuropathy. Pearson correlation analysis showed that plasma chemerin levels were positively related to duration of diabetes, serum creatinine, and 24-hour urine albumin excretion, even after multiple adjustments. Using logistic regression analysis, plasma chemerin concentrations were independently associated with the presence of nephropathy and retinopathy, not neuropathy. Conclusion. This study elucidated a positive correlation between increased chemerin levels and the development of some subtypes of diabetic microangiopathy.
format Article
id doaj-art-f9be7fd7f513428884bc5322135f57c4
institution Kabale University
issn 1687-8337
1687-8345
language English
publishDate 2019-01-01
publisher Wiley
record_format Article
series International Journal of Endocrinology
spelling doaj-art-f9be7fd7f513428884bc5322135f57c42025-02-03T05:51:07ZengWileyInternational Journal of Endocrinology1687-83371687-83452019-01-01201910.1155/2019/86935168693516Increased Circulating Chemerin in Relation to Chronic Microvascular Complications in Patients with Type 2 DiabetesPing Gu0Wei Wang1Yue Yao2Yixin Xu3Liping Wang4Pu Zang5Jian Ma6Cuihua Yang7Junya Liang8Bin Lu9Jiaqing Shao10Department of Endocrinology, Jinling Hospital, School of Medicine, Nanjing University, Nanjing, Jiangsu Province, ChinaDepartment of Endocrinology, Jinling Hospital, School of Medicine, Nanjing University, Nanjing, Jiangsu Province, ChinaDepartment of Endocrinology, Jinling Hospital, School of Medicine, Nanjing University, Nanjing, Jiangsu Province, ChinaDepartment of Endocrinology, Jinling Hospital, School of Medicine, Nanjing University, Nanjing, Jiangsu Province, ChinaDepartment of Endocrinology, Jinling Hospital, School of Medicine, Nanjing University, Nanjing, Jiangsu Province, ChinaDepartment of Endocrinology, Jinling Hospital, School of Medicine, Nanjing University, Nanjing, Jiangsu Province, ChinaDepartment of Endocrinology, Jinling Hospital, School of Medicine, Nanjing University, Nanjing, Jiangsu Province, ChinaDepartment of Endocrinology, Jinling Hospital, School of Medicine, Nanjing University, Nanjing, Jiangsu Province, ChinaHypertension Research Center, Jiangsu Province Hospital of Chinese Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, ChinaDepartment of Endocrinology, Jinling Hospital, School of Medicine, Nanjing University, Nanjing, Jiangsu Province, ChinaDepartment of Endocrinology, Jinling Hospital, School of Medicine, Nanjing University, Nanjing, Jiangsu Province, ChinaObjective. Type 2 diabetes (T2DM) is a global epidemic and increases mortality due to its vascular complications. Chemerin has been found to exert a major role in glucose and lipid metabolism. The aim of this study was to explore the correlation between plasma chemerin levels and microangiopathy in patients with T2DM. Methods. A total of 598 T2DM patients were classified into two groups: with and without microvascular complications. Anthropometric parameters and blood pressure were taken. The amounts of glycosylated hemoglobin, glucose, lipid profiles, creatinine, and chemerin concentrations in the blood were determined. The presence and severity of nephropathy, retinopathy, and neuropathy were also evaluated by specific tests. Results. Plasma levels of chemerin in diabetic subjects with microvascular complications were markedly elevated compared to those without. The number of microvascular complications increased with high plasma chemerin levels. Patients with high chemerin levels had an increased incidence of nephropathy and retinopathy. Furthermore, the chemerin plasma concentrations increased with the progression of diabetic nephropathy with highest values in macroalbuminuria groups. In contrast, no significant difference was observed in plasma chemerin levels between subjects with and without peripheral neuropathy. Pearson correlation analysis showed that plasma chemerin levels were positively related to duration of diabetes, serum creatinine, and 24-hour urine albumin excretion, even after multiple adjustments. Using logistic regression analysis, plasma chemerin concentrations were independently associated with the presence of nephropathy and retinopathy, not neuropathy. Conclusion. This study elucidated a positive correlation between increased chemerin levels and the development of some subtypes of diabetic microangiopathy.http://dx.doi.org/10.1155/2019/8693516
spellingShingle Ping Gu
Wei Wang
Yue Yao
Yixin Xu
Liping Wang
Pu Zang
Jian Ma
Cuihua Yang
Junya Liang
Bin Lu
Jiaqing Shao
Increased Circulating Chemerin in Relation to Chronic Microvascular Complications in Patients with Type 2 Diabetes
International Journal of Endocrinology
title Increased Circulating Chemerin in Relation to Chronic Microvascular Complications in Patients with Type 2 Diabetes
title_full Increased Circulating Chemerin in Relation to Chronic Microvascular Complications in Patients with Type 2 Diabetes
title_fullStr Increased Circulating Chemerin in Relation to Chronic Microvascular Complications in Patients with Type 2 Diabetes
title_full_unstemmed Increased Circulating Chemerin in Relation to Chronic Microvascular Complications in Patients with Type 2 Diabetes
title_short Increased Circulating Chemerin in Relation to Chronic Microvascular Complications in Patients with Type 2 Diabetes
title_sort increased circulating chemerin in relation to chronic microvascular complications in patients with type 2 diabetes
url http://dx.doi.org/10.1155/2019/8693516
work_keys_str_mv AT pinggu increasedcirculatingchemerininrelationtochronicmicrovascularcomplicationsinpatientswithtype2diabetes
AT weiwang increasedcirculatingchemerininrelationtochronicmicrovascularcomplicationsinpatientswithtype2diabetes
AT yueyao increasedcirculatingchemerininrelationtochronicmicrovascularcomplicationsinpatientswithtype2diabetes
AT yixinxu increasedcirculatingchemerininrelationtochronicmicrovascularcomplicationsinpatientswithtype2diabetes
AT lipingwang increasedcirculatingchemerininrelationtochronicmicrovascularcomplicationsinpatientswithtype2diabetes
AT puzang increasedcirculatingchemerininrelationtochronicmicrovascularcomplicationsinpatientswithtype2diabetes
AT jianma increasedcirculatingchemerininrelationtochronicmicrovascularcomplicationsinpatientswithtype2diabetes
AT cuihuayang increasedcirculatingchemerininrelationtochronicmicrovascularcomplicationsinpatientswithtype2diabetes
AT junyaliang increasedcirculatingchemerininrelationtochronicmicrovascularcomplicationsinpatientswithtype2diabetes
AT binlu increasedcirculatingchemerininrelationtochronicmicrovascularcomplicationsinpatientswithtype2diabetes
AT jiaqingshao increasedcirculatingchemerininrelationtochronicmicrovascularcomplicationsinpatientswithtype2diabetes